Neurosurgery

Facts about VHL    Staff   Request E-Consultation   VHL Research   VHL Links    

• Peter M. Black, M.D., Ph.D., Neurosurgery, BWH/CH
• Umberto De Girolami, M.D., Neuropathology, BWH/CH
• Liangge Hsu, M.D., Neuroradiology, BWH
• Robert Jyung, M.D., Otolaryngology, BWH/MEEI
• Ursula Kaiser, M.D., Endocrinology, BWH
• Mark W. Kieran, M.D., Ph.D., Pediatric Neuro-Oncology, DFCI
• Bruce R. Korf, M.D., Ph.D., Genetics/Harvard-Partners Laboratory of Molecular Medicine
• Scott Pomeroy, M.D., Neurology/Neuro-Oncology, CH
• Naren R. Ramakrishna, M.D., Ph.D., Radiation Oncology, BWH
• Julian Seifter, M.D., Nephrology, BWH
• Graeme S. Steele, M.D., Urology, BWH
• Patrick Y. Wen, M.D., Neurology/Neuro-Oncology, BWH/DFCI

Von Hippel-Lindau disease (VHL) is characterized by hemangioblastomas of the brain, spinal cord, and retina; renal cysts and renal cell carcinoma; pheochromocytoma; and endolymphatic sac tumors. The von Hippel-Lindau (VHL) Program at Brigham and Women's Hospital and Dana Farber Cancer Institute is a unique multidisciplinary clinic dedicated to treatment of von Hippel-Lindau patients.

Please contact the Department of Neurosurgery for any inquiries or an appointment at: 617-732-6600.